EventsThe 2nd International Electronic Conference on Clinical Medicine
Published
This submission belongs to the session S6. Mental Health of the event The 2nd International Electronic Conference on Clinical Medicine
Published date
11 Nov, 2024
Academic Editor
author-avatarMichele Roccella
Citation
Jose Joaquin Merino, María Eugenia Cabaña-Muñoz, José María Parmigiani-Cabaña, Adolfo Toledano Gasca, José María Parmigiani-Izquierdo, CX3CL1 delta chemokine is a chronic inflammatory mediator that links periodontitis with Alzheimer disease in patients, in Proceedings of The 2nd International Electronic Conference on Clinical Medicine, 13 November–15 November 2024, MDPI: Basel, Switzerland
Share
Email
Facebook
Twitter
LinkedIn

CX3CL1 delta chemokine is a chronic inflammatory mediator that links periodontitis with Alzheimer disease in patients

José María Parmigiani-Cabaña 3
José María Parmigiani-Izquierdo 3
1. UCM (Universidad Complutense de Madrid), Dpto. Farmacología, Farmacognosia y Botánica (UCM), IUIN, Spain, Spain
2. Private Dentist Practice, Private Clinic, 30001 Murcia, Spain., Spain
3. Clinica CIROM, Murcia, Spain, Spain
4. Cajal Institute CSIC, Madrid, Spain, Spain
Abstract

Titanium is considered a biocompatible biomaterial of dental titanium alloys (Ti-6Al-4V). However, patients with certain dental metals (Hg++, Al, Ti, etc.), including dental Ti implants, can provoke a chronic silent inflammatory state.

On the other hand, periodontitis favours the adherence of biofilms on the surface of teeth, increasing the local recruitment of innate immune cells (neutrophils, macrophages, and dendritic cells). Thus, a chornic proinflammaotry cytokine release of cytokine/chemokines, including CX3CL1, can amplify the local inflammatory resposnes and also promote oral disbiosis. In fact, recent studies link Alzheimer's disease (AD) with periodontitis. However, systemic CX3CL1 and MCP-1 elevations can be also detected in patients with long-term dental Ti implants without periodontisis. The periodontisis favours the teeth destruction and also enhances the accumulation of oral biofilm. In fact, porphyromonas gingivalis has been associated with AD, and high systemic CX3CL1 levels have been found to contribute to p-Tau accumulation in the brain of AD transgenic mices.

Thus, this CX3CR1 overexpression as a chronic silent proinflammatory response can predispose patients with periodontal disease and poor bucal higiene to AD. Collectivelly, CX3CR1 overproduction affects the normal control of the inhate inmune system and favours the destruction of the supporting tissues of the teeth in patients with periodontal disease. Thus, the link between AD and periodontitis via CX3CL1 opens up a new therapeutic role of delta chemokine blockers against periodontitis and AD pathology.

Keywords
CX3Cl1,
chemokines
periodontitis
neurodegenerative diseases
Access to vaccination for newly arrived migrants in Poland: Evidence and implications for action (AcToVax4NAM project)
Genetic Variations and Drug Response in Gastroesophageal Reflux Disease (GERD): The Role of Pharmacogenomic Testing in Optimizing Proton Pump Inhibitor (PPI) Therapy